跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 1g powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 1g powder for injection vial
Approved
STANDARD
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 1g powder for injection vial
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d0b646c384018bd9
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
d0b646c384018bd9
Product Name
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 1g powder for injection vial
Artg Id
277680
Artg Name
CEFTAZIDIME-AFT ceftazidime (as pentahydrate) 1 g powder for injection vial
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2017-09-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02467-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-02466-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d0b646c384018bd9
Type
Standard
Back to TGA Approvals